Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Kellen currently holds 162,000 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Kellen has been a net buyer of DMAC stock. They have purchased $119.0K and sold $0 worth of shares.
Scott Kellen's most recent insider trade was on Jun 1, 2026, when they sold 162,000 shares at $0.00 per share.
Scott Kellen serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 13 insider transactions totaling $119.0K over their tenure at the company.
Scott Kellen holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Scott Kellen has shown a buying trading pattern, with $119.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Kellen was on Jun 23, 2023, when they purchased $39.1K worth of DMAC shares. This transaction involved 10,000 shares at $3.91 per share.
Scott Kellen currently owns 162,000 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Kellen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Kellen has 13 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for Scott Kellen and 40,000+ other insiders.